Bringing the fundamentals into focus…
Back to Janux Therapeutics, Inc.
How Janux Therapeutics, Inc. stacks up
JANX · against 463 other Healthcare companies of similar size
Profitability
7/ 100
Near the bottom of its peers.
Ranked #435 of 464 · scores higher than 6% of peers
Bars: peers in each 10-point band of the profitability score36 peers with a profitability score of 0–9, including JANX · Click a bar to see the companies
Why profitability scores 7?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 94% of peers. Operating margin: -598.1% vs peer median 7.1%
- a lower return on assets: weaker than 75% of peers. Return on assets: -10.2% vs peer median 1.7%
- a lower return on invested capital: weaker than 75% of peers. Return on invested capital: -12.6% vs peer median 4.7%
Metric by metric
Position: dot = JANX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | JANX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 438 reported | -12.6% | 4.6% | 22% | 33% | |
| Operating marginHigher is better · 435 reported | -598.1% | 6.8% | 6% | 33% | |
| Return on assetsHigher is better · 450 reported | -10.2% | 1.6% | 21% | 33% | |
| Return on equityHigher is better · 433 reported | -10.7% | 2.9% | 28% | Context only | |
| Gross marginHigher is better · 483 reported | 0.0% | 47.7% | 2% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around JANX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 3 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 3 | 595M USD | 99 | 97 | |
| 3 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 429 | 730M USD | 9 | 11 | |
| 433 | 1.9B USD | 8 | 18 | |
| 433 | 885M USD | 8 | 33 | |
| 435 | 1.1B USD | 7 | 26 | |
| 435 | 1.1B USD | 7 | 50 | |
| 435 | 705M USD | 7 | 32 | |
| 438 | 888M USD | 6 | 25 | |
| 438 | 879M USD | 6 | 36 | |
| 438 | 1.5B USD | 6 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score